Transcription of NEW ZEALAND DATA SHEET - Medsafe
{{id}} {{{paragraph}}}
Example: marketing
NEW ZEALAND DATA SHEET - Medsafe
NEW ZEALAND data SHEET ASACOL data SHEET 15 January 2018 Page 1 of 14 Emerge Health NZ Ltd 1 ASACOL Asacol 400mg enteric coated tablet Asacol 800mg enteric coated tablet Asacol w/w suppository 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredient Asacol 400mg enteric coated tablet: Mesalazine (5-aminosalicylic acid, 5-ASA) 400mg in each enteric coated (gastro-resistant) tablet. Excipient with known effect: lactose, see section Asacol 800mg enteric coated tablet: Mesalazine (5-aminosalicylic acid, 5-ASA) 800mg in each enteric coated (gastro-resistant) tablet. Excipient with known effect: lactose, see section Asacol w/w (500mg) suppository: Mesalazine (5-aminosalicylic acid, 5-ASA) w/w (500mg) in each suppository.
NEW ZEALAND DATA SHEET ASACOL Data Sheet 15 January 2018 Page 1 of 14 Emerge Health NZ Ltd 1 ASACOL Asacol 400mg enteric coated tablet Asacol 800mg enteric coated tablet
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Development of mesalazine pellets coated, Review of the FDA Dissolution Methods, Development, Dosage Form Design: Pharmaceutical and, Controlled-Release Capsule Formulation: Challenges and Solutions, Q5C Stability testing of Biotechnological /, Q5C - Stability testing of Biotechnological / Biological, Monocytosis, Oral drug delivery